benzatropine
A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.
Ligand Summary
UNII: 1NHL2J4X8K
PubChem: 1201549
Guide to Pharmacology: 7601
ChEMBL: CHEMBL1201203
DrugCentral: 333
LyCHI: 1GT44A3AKFB7
Target Activities
SLC6A3
Sodium-dependent dopamine transporter
5 Activities
Items per page:
1 – 5 of 5
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 6.93 | |||||
Ki | 6.71 | None, None:None:None | ||||
IC50 | 6.61 | None, None:None:None | ||||
IC50 | 6.51 | J. Med. Chem., (1994) 37:13:2001 | ||||
IC50 | 6.51 | J. Med. Chem., (1996) 39:2:371 | ||||
CHRM1
Muscarinic acetylcholine receptor M1
4 Activities
Items per page:
1 – 4 of 4
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 9.02 | |||||
Ki | 9.88 | None, None:None:None | ||||
IC50 | 9.26 | None, None:None:None | ||||
Ki | 9.64 | ANTAGONIST | ||||
CHRM2
Muscarinic acetylcholine receptor M2
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 8.59 | |||||
Ki | 8.44 | None, None:None:None | ||||
IC50 | 8 | None, None:None:None | ||||
CHRM3
Muscarinic acetylcholine receptor M3
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 9.56 | None, None:None:None | ||||
IC50 | 8.89 | None, None:None:None | ||||
CHRM4
Muscarinic acetylcholine receptor M4
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 9.48 | None, None:None:None | ||||
IC50 | 8.62 | None, None:None:None | ||||
HRH1
Histamine H1 receptor
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 9.43 | None, None:None:None | ||||
IC50 | 8.5 | None, None:None:None | ||||
SIGMAR1
Sigma non-opioid intracellular receptor 1
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 7.23 | None, None:None:None | ||||
IC50 | 6.86 | None, None:None:None | ||||
ADRA1D
Alpha-1D adrenergic receptor
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 7.58 | None, None:None:None | ||||
IC50 | 7.28 | None, None:None:None | ||||
ADRA2B
Alpha-2B adrenergic receptor
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 7.52 | None, None:None:None | ||||
IC50 | 7.19 | None, None:None:None | ||||
HTR2A
5-hydroxytryptamine receptor 2A
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 8.16 | None, None:None:None | ||||
IC50 | 7.62 | None, None:None:None | ||||
HTR2C
5-hydroxytryptamine receptor 2C
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 7.5 | None, None:None:None | ||||
IC50 | 7.21 | None, None:None:None | ||||
CHRM5
Muscarinic acetylcholine receptor M5
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 8.84 | None, None:None:None | ||||
IC50 | 8.7 | None, None:None:None | ||||
SLC6A19
Sodium-dependent neutral amino acid transporter B(0)AT1
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | 4.36 | |||||
ADRA2C
Alpha-2C adrenergic receptor
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 7.24 | None, None:None:None | ||||